- This focused review synthesizes neurophysiological mechanisms of central nervous system sensitization across peripartum pain conditions.
- It covers lumbopelvic pain, labor pain, persistent postpartum and perineal pain, and chronic postcesarean pain, as well as psychological factors such as anxiety and catastrophizing.
- The authors argue that psychological factors may actively modulate central pain processing rather than merely coexist, making them potential modifiable targets.
- Key gaps include the lack of obstetric-specific validation for the Central Sensitization Inventory and limited prospective data linking intraprocedural nociception to postprocedural sensitization.
Obstetric
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This systematic review with narrative synthesis pooled 30 studies covering 28,295 women reporting outcomes at least 3 months after caesarean delivery.
- Chronic postsurgical pain after caesarean was compared against no-pain or differently characterised groups across quality of life domains, since the included studies varied in pain definitions and measures.
- Activity interference was most prominent at 3 months (54%), while mood interference was higher at 6 months (53%) and 12 months (68%); postpartum depression ranged from 7% to 46% in the first year.
- The authors conclude that chronic pain after caesarean is linked to clinically important impairment across several domains, with function dominating early and affective interference becoming relatively more prominent later, supporting multidimensional outcome assessment.
- Systematic review and network meta-analysis of 12 studies including 2,017 parturients, assessing the ObsQoR-10 recovery measure after childbirth.
- Estimated the minimal clinically important difference by triangulating distribution-based methods (half the SD) with anchor-based comparisons of delivery mode and planned versus unplanned caesarean.
- Distribution-based estimates ranged from 6.7 (95%CI 6.0-7.6) to 8.7 (95%CI 7.9-9.6), while anchor-based estimates ranged from 9.7 (95%CI 2.7-16.5) to 12.4 (95%CI 3.1-21.5).
- The authors recommend a minimal clinically important difference of 7-10 points, with 7 as the lower bound, and report moderate evidence for validity, reliability and responsiveness.
- This narrative review draws on PubMed, Google Scholar, reference lists, and intrathecal pump device manuals to cover perioperative, obstetric, and ICU care of patients with implanted intrathecal drug delivery systems.
- It is organized into five sections: intrathecal pharmacology, implantation considerations, perioperative care, neuraxial anesthesia, and device-related safety concerns.
- Where evidence is limited, the authors supplement the literature with expert opinion, so some recommendations rest on consensus rather than data.
- The authors highlight intrathecal medications, their behavior under MRI, and precautions before any neuraxial access in these patients.
- This narrative review synthesizes current evidence on GLP-1 and dual GLP-1/GIP receptor agonists for obstetric and gynecologic practice, with a focus on women's health.
- Phase 3 trials report 15-21% body weight reduction, with tirzepatide described as superior to semaglutide, and PCOS meta-analyses report improved insulin resistance, androgen levels, and ovulation rates.
- Manufacturer guidance advises backup contraception for 4 weeks after tirzepatide initiation or dose escalation, because the drug significantly delays gastric emptying.
- Early human cohort studies of inadvertent early pregnancy exposure report no increased risk of major congenital malformations, which the authors describe as preliminary reassurance.